Mark Baum

Mr. Baum is a founder, board member & CEO of Imprimis Pharmaceuticals, Inc. Beginning in 2011, he led the restructuring & reorganization of Imprimis, including raising nearly $25M in new equity capital to support building Imprimis’ novel pharmaceutical innovation & distribution business. Prior he was the founder & managing director of California-based TBLF, LLC, where he managed a series of three funds, acting as a principal investor primarily in financing publicly traded companies or bridge-to-public-equity transactions. Mr. Baum is the chairman of the board of directors for Ideal Power, Inc. & chairman of the board of directors of Endra, Inc. Mr. Baum is a published inventor & is an inactive member of both the State Bar of California & the State Bar of Texas.